NCT00902304
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
See it on ClinicalTrials.gov ↗1,562 people
38.3%
61.7%
599 womenmiddle line = equal numbers963 men
- Phase
- PHASE4
- Paid for by
- Novartis Pharmaceuticals
- Finished
- 2011-07
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 59 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Some results split by sex
- Race
- Not reported
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“severe kidney disease or dialyses”
Study titles and rules are shown in their original English.